GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,394.50p
   
  • Change Today:
      32.00p
  • 52 Week High: 1,788.50
  • 52 Week Low: 1,264.00
  • Currency: UK Pounds
  • Shares Issued: 4,103.57m
  • Volume: 9,852,850
  • Market Cap: £57,224m
  • RiskGrade: 129
  • Beta: 0.00

Largest Deals (365 days)

Show trades greater than:
Traded Action Notifier PriceAmountValue
21-Feb-25 Buy Hal Barron 3,664.00p 3,269,946 £119,810,819.44
10-Feb-25 Sell Emma Walmsley 1,453.19p 120,653 £1,753,317.38
18-Feb-25 Sell Hal Barron 2,904.38p 24,623 £715,144.39
17-Feb-25 Sell Emma Walmsley 1,418.18p 38,459 £545,417.84
25-Mar-25 Buy Charles Bancroft 2,997.61p 15,843 £474,911.83
25-Mar-25 Buy Jesse Goodman 2,997.61p 6,842 £205,096.68
16-Aug-24 Buy Dividends Hal Barron 4,128.00p 2,735 £112,907.49
30-Oct-24 Buy Jonathan Symonds 1,393.65p 7,150 £99,645.97
15-Nov-24 Buy Hal Barron 2,643.57p 3,447 £91,126.43
16-Jul-24 Buy Hal Barron 2,985.56p 2,859 £85,363.23
06-May-25 Sell Emma Walmsley 1,448.96p 5,473 £79,301.58
20-Mar-25 Buy Charles Bancroft 3,029.51p 1,969 £59,650.95
16-Apr-25 Buy Dividends Emma Walmsley 1,275.00p 4,930 £62,857.50
23-Sep-24 Buy Charles Bancroft 1,536.13p 3,602 £55,331.55
20-Dec-24 Buy Charles Bancroft 1,345.06p 4,368 £58,752.23
20-Jun-24 Buy Charles Bancroft 3,220.87p 1,811 £58,329.90
10-Apr-25 Buy Dividends Emma Walmsley 1,306.68p 4,560 £59,584.61
15-Oct-24 Buy Dividends Emma Walmsley 1,505.00p 3,618 £54,450.90
20-Jun-24 Buy Vishal Sikka 3,220.87p 1,179 £37,974.02
20-Jun-24 Buy Jonathan Symonds 1,614.53p 2,000 £32,290.60

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,394.50p
Change Today 32.00p
% Change 2.35 %
52 Week High 1,788.50
52 Week Low 1,264.00
Volume 9,852,850
Shares Issued 4,103.57m
Market Cap £57,224m
Beta 0.00
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
38.15% below the market average38.15% below the market average38.15% below the market average38.15% below the market average38.15% below the market average
19.15% above the sector average19.15% above the sector average19.15% above the sector average19.15% above the sector average19.15% above the sector average
Price Trend
4.32% below the market average4.32% below the market average4.32% below the market average4.32% below the market average4.32% below the market average
40.43% above the sector average40.43% above the sector average40.43% above the sector average40.43% above the sector average40.43% above the sector average
Income
76.29% above the market average76.29% above the market average76.29% above the market average76.29% above the market average76.29% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
39.08% below the market average39.08% below the market average39.08% below the market average39.08% below the market average39.08% below the market average
48.39% below the sector average48.39% below the sector average48.39% below the sector average48.39% below the sector average48.39% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 14
Sell 3
Strong Sell 1
Total 24
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 15-May-25 20-Feb-25
Paid 10-Jul-25 10-Apr-25
Amount 16.00p 16.00p

Trades for 16-May-2025

Time Volume / Share Price
16:20 0 @ 1,397.00p
16:20 0 @ 1,397.00p
16:20 0 @ 1,397.00p
16:20 0 @ 1,397.00p
16:20 0 @ 1,397.00p

GSK Key Personnel

CEO Emma Walmsley

Top of Page